• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Business/Financial News

Baxter sees shares lift on Street-beating Q1 earnings release

April 26, 2017 By Fink Densford

Bax

Baxter (NYSE:BAX) shares have risen today after the medical device company topped expectations on Wall Street with its 1st quarter earnings results. The Deerfield, Ill.-based company posted profits of $272 million, or 50¢ per share, on sales of $2.48 billion for the 3 months ended March 31. The company saw its bottom line shrink 92% while […]

Filed Under: Business/Financial News Tagged With: Baxter International

23andMe is back: FDA allows marketing of genetic health risk tests

April 21, 2017 By Chris Newmarker

23andMe

FDA this month allowed genetic testing company 23andMe to market genetic health risk tests for 10 diseases and conditions including Parkinson’s disease and late-onset Alzheimer’s disease. The de novo premarket review authorization, announced April 6, also included celiac disease, which results in the inability to digest gluten; alpha-1 antitrypsin deficiency, which raises the risk of […]

Filed Under: Business/Financial News, Diagnostics, Featured, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: 23andme, FDA, medtech

Brexit effects on Authorized Representatives in EU and UK

April 20, 2017 By Danielle Kirsh

By Ronald Boumans, Emergo Group On 29 March 2017, the United Kingdom’s ambassador to the European Union delivered a formal letter invoking Article 50 of the Treaty of the EU to the President of the European Council. This means the UK will leave the European Union in two years at the latest. The date of […]

Filed Under: Business/Financial News Tagged With: blog, Emergo Group

Verily launches biosensor-equipped Study Watch for clinical study patient monitoring

April 17, 2017 By Fink Densford

Verily's Study Watch

Verily Life Sciences, the medical arm of Google parent Alphabet (NSDQ:GOOGL), today unveiled its Study Watch, a wearable device designed to passively capture health data. The watch, intended to create a method of unobtrusive biosensing, is equipped with multiple sensors, including an electrocardiogram, and can monitor heart rate, electrodermal activity and inertial movements, with a battery life of up […]

Filed Under: Business/Financial News, Clinical Trials, Patient Monitoring Tagged With: Google, Verily

How Boston Sci is getting drug-eluting stents and balloons into legs

April 13, 2017 By Chris Newmarker

Boston Scientific officials think they have a leg up when it comes to bringing drug-eluting technology to bear on peripheral artery disease. That’s because the medical device giant has decades of experience with balloons and drug-eluting stents used around the heart. When it comes to treating the narrowing arteries in the legs and thighs, Boston […]

Filed Under: Business/Financial News, Cardiovascular, Drug-Device Combinations, Featured, Stents, Vascular Tagged With: Boston Scientific, drug-eluting balloons, drug-eluting stents, medtech

How artificial life spawned a billion-dollar industry

April 6, 2017 By Sarah Faulkner

How artifical life spawned a billion-dollar industry

(Reuters) – Scientists are getting closer to building life from scratch and technology pioneers are taking notice, with record sums moving into a field that could deliver novel drugs, materials, chemicals and even perfumes. Despite ethical and safety concerns, investors are attracted by synthetic biology’s wide market potential and the plummeting cost of DNA synthesis, […]

Filed Under: Business/Financial News, Discovery, Featured, Research & Development, Technology, Wall Street Beat

Medtech stories we missed this week: March 31, 2017

March 31, 2017 By Danielle Kirsh

This week we saw a few FDA 510(k) clearances and one of the 1st uses of a next-generation surgical robot in Asia. Here are medtech stories we missed this week but thought were still worth mentioning: 1. Corindus touts first Asian use of next-generation robot Corindus Vascular Robotics announced in a March 31 press release that robot-assisted […]

Filed Under: Business/Financial News, Clinical Trials, Food & Drug Administration (FDA), Personnel, Regulatory/Compliance, Research & Development Tagged With: Aminox, Bodycad, corindus, Engologix, medtech, NeoSurgical, NeoTract, Providence Medical, TissueTech

Short of votes, Trumpcare bill is withdrawn

March 24, 2017 By Fink Densford

capitol hill

Republican leaders in the US House of Representatives today withdrew the GOP-backed Trumpcare bill, which aimed to begin dismantling and replacing Obamacare, due to a shortage of votes. A vote on the measure was planned after Trump cut off negotiations with Republicans who had balked at the plan and issued an ultimatum to vote on […]

Filed Under: Business/Financial News Tagged With: Capitol Hill

The top medtech stories of early 2017

March 24, 2017 By Chris Newmarker

Donald Trump top medtech stories

The new Trump administration and Republican Congress – and all the accompanying change and uncertainty – is the major story for the medical device industry. But there are many other medtech stories worth noting from the first quarter of 2017. There was an FDA warning over Abbott’s Absorb bioresorbable stent, a continued spate of M&A deals, diabetes […]

Filed Under: Business/Financial News, Diabetes, Featured, Food & Drug Administration (FDA), Mergers & Acquisitions Tagged With: Abbott Laboratories, Absorb, Affordable Care Act, Diabetes, Donald Trump, Insulet, medtech, Obamacare, Omnipod

Do patient advocacy organizations have a conflict of interest?

March 22, 2017 By Chris Newmarker

money conflict of interest

At least 83% of U.S. patient advocacy organizations receive financial support from medical device, drug and biotechnology companies, according to new research out of the University of Pennsylvania’s Department of Medical Ethics and Health Policy. The Penn research team – which included Matthew McCoy, Harald Schmidt and Ezekiel Emanuel – examined websites and annual reports for 104 organizations […]

Filed Under: Business/Financial News, Featured, Legal News, Patient Monitoring, Preclinical Trials, Research & Development Tagged With: conflict of interest, medtech, National Health Council, patient advocacy organizations, University of Pennsylvania

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 184
  • Page 185
  • Page 186
  • Page 187
  • Page 188
  • Interim pages omitted …
  • Page 195
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS